Literature DB >> 22159584

CHFR: a key checkpoint component implicated in a wide range of cancers.

Sheru Sanbhnani1, Foong May Yeong.   

Abstract

CHFR (Checkpoint with Forkhead-associated and RING finger domains) has been implicated in a checkpoint regulating entry into mitosis. However, the details underlying its roles and regulation are unclear due to conflicting lines of evidence supporting different notions of its functions. We provide here an overview of how CHFR is thought to contribute towards regulating mitotic entry and present possible explanations for contradictory observations published on the functions and regulation of CHFR. Furthermore, we survey key data showing correlations between promoter hypermethylation or down-regulation of CHFR and cancers, with a view on the likely reasons why different extents of correlations have been reported. Lastly, we explore the possibilities of exploiting CHFR promoter hypermethylation status in diagnostics and therapeutics for cancer patients. With keen interest currently focused on the association between hypermethylation of CHFR and cancers, details of how CHFR functions require further study to reveal how its absence might possibly contribute to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159584     DOI: 10.1007/s00018-011-0892-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  116 in total

Review 1.  Triggering the all-or-nothing switch into mitosis.

Authors:  P H O'Farrell
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

Review 2.  Ubiquitin and ubiquitin-like proteins as multifunctional signals.

Authors:  Rebecca L Welchman; Colin Gordon; R John Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

3.  The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.

Authors:  Yasuo Koga; Yoshihiko Kitajima; Atsushi Miyoshi; Ken Sato; Seiji Sato; Kohji Miyazaki
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

Review 4.  Tip60: connecting chromatin to DNA damage signaling.

Authors:  Yingli Sun; Xiaofeng Jiang; Brendan D Price
Journal:  Cell Cycle       Date:  2010-03-11       Impact factor: 4.534

5.  Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.

Authors:  Kangmei Chen; Raja Sawhney; Mumtaz Khan; Michael S Benninger; Zizheng Hou; Seema Sethi; Josena K Stephen; Maria J Worsham
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-11

6.  Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

Authors:  Lisa M Privette; Maria E González; Lei Ding; Celina G Kleer; Elizabeth M Petty
Journal:  Cancer Res       Date:  2007-06-27       Impact factor: 12.701

Review 7.  Structure and function of the phosphothreonine-specific FHA domain.

Authors:  Anjali Mahajan; Chunhua Yuan; Hyun Lee; Eric S-W Chen; Pei-Yu Wu; Ming-Daw Tsai
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

8.  Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.

Authors:  Ivan Ahel; Dragana Ahel; Takahiro Matsusaka; Allison J Clark; Jonathon Pines; Simon J Boulton; Stephen C West
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

9.  The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.

Authors:  Dongmin Kang; James Chen; Jim Wong; Guowei Fang
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

Review 10.  The decision to enter mitosis: feedback and redundancy in the mitotic entry network.

Authors:  Arne Lindqvist; Verónica Rodríguez-Bravo; René H Medema
Journal:  J Cell Biol       Date:  2009-04-13       Impact factor: 10.539

View more
  15 in total

1.  Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.

Authors:  Rob Noorlag; Pauline M W van Kempen; Cathy B Moelans; Rick de Jong; Laura E R Blok; Ronald Koole; Wilko Grolman; Paul J van Diest; Robert J J van Es; Stefan M Willems
Journal:  Epigenetics       Date:  2014-07-08       Impact factor: 4.528

Review 2.  Spatiotemporal regulation of the Dma1-mediated mitotic checkpoint coordinates mitosis with cytokinesis.

Authors:  Sierra N Cullati; Kathleen L Gould
Journal:  Curr Genet       Date:  2019-01-02       Impact factor: 3.886

Review 3.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

4.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23

Review 5.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

6.  Defective in mitotic arrest 1 (Dma1) ubiquitin ligase controls G1 cyclin degradation.

Authors:  Sara Hernández-Ortega; Samuel Bru; Natalia Ricco; Sara Ramírez; Núria Casals; Javier Jiménez; Marta Isasa; Bernat Crosas; Josep Clotet
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

7.  The eukaryotic translation initiation regulator CDC123 defines a divergent clade of ATP-grasp enzymes with a predicted role in novel protein modifications.

Authors:  A Maxwell Burroughs; Dapeng Zhang; L Aravind
Journal:  Biol Direct       Date:  2015-05-15       Impact factor: 4.540

8.  TOPK and PTEN participate in CHFR mediated mitotic checkpoint.

Authors:  Swapnil R Shinde; Narmadha Reddy Gangula; Sridhar Kavela; Vimal Pandey; Subbareddy Maddika
Journal:  Cell Signal       Date:  2013-09-03       Impact factor: 4.315

9.  Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton.

Authors:  S Mithraprabhu; T Khong; A Spencer
Journal:  Cell Death Dis       Date:  2014-03-20       Impact factor: 8.469

10.  Epigenetic silencing of checkpoint with fork-head associated and ring finger gene expression in esophageal cancer.

Authors:  Yoshihiro Suzuki; Yohei Miyagi; Norio Yukawa; Yasushi Rino; Munetaka Masuda
Journal:  Oncol Lett       Date:  2013-11-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.